Table 2.
Subjects | Dose (mg d–1) | Bioavailability | Half‐life (h) | Renal excretion (%) | Solubility | |
---|---|---|---|---|---|---|
Atorvastatina | 4 | 20–80 | 12% | 14 | 5 | Lipophilic |
Pitavastatina | 2 | 2–2 | 80% | 11 | NA | Lipophilic |
Simvastatina | 2 | 10–20 | 5% | 2 | 13 | Lipophilic |
Rosuvastatina | 2 | 10–20 | 20% | 19 | 10 | Hydrophilic |
Schachter64